Illumina reagents and services

Open State & local contract opportunity Posted

Solicitation number
SS-17411
State
Florida
Responses due

Opportunity facts

Jurisdiction
Point of contact

Opportunity details come from vendor.myfloridamarketplace.com. Updated .

About this opportunity

The Florida Department of Health's Bureau of Public Health Laboratories (BPHL) intends to purchase Illumina MiSeq, iSeq, and NextSeq system reagents and services as a single source from Illumina, Inc., with a receipt-of-information deadline of December 1, 2026 at 5:00 p.m. The sole-source intent under Chapter 60A-1.045, Florida Administrative Code, is the decision-flipping constraint: this is a Description of Intended Single Source Purchase (PUR 7776), not an open competitive solicitation, and the file identifies no set-asides.

The reagents and services support nucleic acid sequence identification for outbreak detection of enteric and viral diseases, a requirement of the Centers for Disease Control and Prevention (CDC), and for validated testing of clinical samples. Illumina is identified as the sole manufacturer and distributor of the required systems and is described as the only CDC-approved kit provider for SARS-CoV-2, HIV, Hepatitis A, TB, and foodborne pathogens that examines mutations, with reagents, instrumentation, and software included. The stated justification is continuity with these specialized reagents and services as being in the best interest of the state.

The estimated purchase amount is $4.26 million over a three-year term. The place of performance is Florida, within Leon County. The purchase was approved by Sonja German-Jones, Purchasing Director. Keshauna Johnson, Department of Health, at (850) 558-9723 or Keshauna.Johnson@flhealth.gov, is the point of contact. The posting date is November 5, 2026, and the internal tracking number is EXP2696.

Opportunity text

The Department of Health's, Bureau of Public Health Laboratories has the need to purchase the Illumina MiSeq®, iSeq ®, and NextSeq ® system reagents and services for the identification of nucleic acid sequences. These instruments and reagents will support the outbreak detection activities for enteric and viral diseases and are required by the Centers for Disease Control and Prevention (CDC).


In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization to purchase, as a single source, the MiSeq®, iSeq ®, and NextSeq ® System reagents and services from Illumina, Inc.

Files

File Type Posted
EXP2696_PUR7776 Final.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for State & Local Contractors